DataMeds AI and Tollo Health have teamed up with the National Football League Alumni Association, through its subsidiary Alumni Health, to initiate the Health Lives Here national health campaign. This collaboration is designed to enhance access to healthcare information, pharmacy services, and health-management tools, with a particular focus on underserved and rural communities. The campaign will utilize DataMeds AI’s extensive network of over 6,500 independent pharmacies to promote healthy living awareness while offering consumers discounted pharmacy services and various healthcare resources.
A central component of this initiative is the forthcoming Health Lives Here mobile application, a telehealth and health-management platform centered around consumer needs. The app is set to enable users to consolidate electronic health records and synchronize data from wearable devices into a single health dashboard. Additionally, it will offer access to pharmacy-based services and select healthcare products, creating a comprehensive digital health solution for users.
The Health Lives Here initiative was first presented to professional football alumni during the 2026 Football Hall of Fame Game weekend held in Canton, Ohio. The campaign is slated for a broader public rollout in North Carolina in September 2026. Further details regarding the mobile application, participating pharmacies, and the overall campaign rollout are anticipated to be shared in the coming months.
This partnership effectively combines Tollo Health’s expertise in medical food and nutraceutical products with DataMeds AI’s cutting-edge healthcare technology and pharmacy infrastructure. The NFL Alumni Association’s health network will play a crucial role in reaching out to communities and former professional football players, ensuring the initiative’s success and impact.
For those seeking additional information, DataMeds AI can be contacted through James Lambert, Vice President at Rubenstein Public Relations, at 212-805-3024 or via email at [email protected]. Investor inquiries can be directed to Investor Relations at [email protected], and further details are available on their website at https://datamedsai.com/.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.